SCHEMBL29650282

SCHEMBL29650282

CCS(=O)(=O)c1cccc(O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSIP1 O75475 2/20 0.56
HSD17B1 P14061 4/20 0.51
HSD17B2 P37059 4/20 0.51
ALDH1A1 P00352 3/20 0.47
CYP3A4 P08684 2/20 0.47
CA2 P00918 2/20 0.44
CA12 O43570 1/20 0.44
LMNA P02545 1/20 0.44
CA5A P35218 1/20 0.44
CA9 Q16790 1/20 0.44
HSD17B10 Q99714 1/20 0.44
CA14 Q9ULX7 1/20 0.44
CA5B Q9Y2D0 1/20 0.44
TSHR P16473 2/20 0.42
MMP2 P08253 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
BRD4 O60885 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2642996 1.00 PSIP1 (0.56) PSIP1HSD17B1HSD17B2ALDH1A1CYP3A4
SCHEMBL11331630 0.86 HSD17B1 (0.47) PSIP1HSD17B1HSD17B2ALDH1A1CYP3A4
SCHEMBL17263850 0.84 PSIP1 (0.68) PSIP1ALDH1A1CYP3A4CA2LMNA
SCHEMBL31385343 0.83 HSD17B1 (0.45) HSD17B1HSD17B2ALDH1A1CYP3A4CA2
SCHEMBL10085540 0.82 HSD17B2 (0.46) HSD17B1HSD17B2ALDH1A1CYP3A4CA2
Phenol SCHEMBL28291911 0.81 PSIP1 (0.78) PSIP1ALDH1A1CA2CA12CA9
SCHEMBL11693054 0.81 ESR1 (0.48) HSD17B1HSD17B2CA2CA12CA9
SCHEMBL9162922 0.80 CA2 (0.48) HSD17B1HSD17B2ALDH1A1CYP3A4CA2
SCHEMBL644484 0.80 MEN1 (0.53) PSIP1HSD17B1HSD17B2CYP3A4CYP1A2
SCHEMBL8132585 0.79 PSIP1 (0.56) PSIP1ALDH1A1CA2HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109563103-B Modulators of beta-3 adrenergic receptors for the treatment or prevention of disorders related thereto 艾尼纳制药公司 2022-05-27 CN disclosed